HONG KONG, March 14, 2017 /PRNewswire/ -- DKSH Business Unit Healthcare, Asia's leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia, has been appointed by Johnson & Johnson, a leading multinational healthcare company, to grow its consumer health business in Hong Kong. Under the agreement, a dedicated DKSH team will provide marketing, sales, distribution and logistics activities in both the retail and in professional healthcare outlets such as hospitals, clinics, doctors or pharmacies all over Hong Kong.
The new partnership with Johnson & Johnson follows an earlier announcement where DKSH has been appointed by the consumer goods multinational Procter & Gamble to sell and distribute their brands in Hong Kong. The agreement is as well another proof that in more complex market conditions, clients tend to increasingly outsource parts of the value chain to market expansions services providers like DKSH.
The broad range of Johnson & Johnson's brand products under the agreement include Regaine, Listerine, Aveeno, Neutrogena, Anusol, Gelusil, Imodium, Nicorette, Nizoral, Pregaine, Trosyd, Bandaid, Carefree as well as Johnson's baby. In total, DKSH will look after more than 20 brands from Johnson & Johnson.
"The fact that major healthcare company like Johnson & Johnson outsources a significant part of the business to DKSH underlines our strong position in the Asian market. Our direct reach, dedication to marketing and sales as well as our unique capillary distribution make us the leading partner for growth. The trust from the client to grow its business in Hong Kong is a big boost for us to outperform in the market," said Grace Lau, Vice President, Business Unit Healthcare, DKSH Hong Kong.
About Johnson & Johnson
Johnson & Johnson is the world's most comprehensive and broadly-based healthcare company, with businesses in three sectors: consumer; pharmaceuticals and medical devices. The company established its first joint venture, Xian Janssen, in China in 1985. Guided by Our Credo, Johnson & Johnson is dedicated to the aspiration of "caring for the world, one person at a time" by bringing innovative ideas, products and services to advance the health and well-being of people. Our employees work with partners in health care to touch the lives of over a billion people every day, throughout the world.
DKSH is the leading Market Expansion Services provider with a focus on Asia. As the term "Market Expansion Services" suggests, DKSH helps other companies and brands to grow their business in new or existing markets. Publicly listed on the SIX Swiss Exchange since 2012, DKSH is a global company headquartered in Zurich. With 780 business locations in 36 countries -- 750 of them in Asia -- and 30,320 specialized staff, DKSH generated net sales of CHF 10.5 billion in 2016. DKSH was founded in 1865. With strong Swiss heritage, the company has a long tradition of doing business in and with Asia and is deeply rooted in communities and businesses across Asia Pacific.
DKSH Business Unit Healthcare is the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia. Custom-made offerings comprise registration, regulatory services, market entry studies, importation, customs clearance, marketing and sales, capillary physical distribution, invoicing and cash collection. Products available through DKSH Healthcare include pharmaceuticals, consumer health and over-the-counter (OTC) products as well as medical devices. With 120 business locations in 13 countries and around 9,740 specialized staff, Business Unit Healthcare serves over 150,000 customers and generated net sales of CHF 5.5 billion in 2016.